Small medical practices are under financial stress due to a cyberattack, according to the American Medical Association (AMA). Among the concerns reported in an AMA survey conducted from March 26 to April 3 were ongoing suspension in claims payment, inability to submit requests, and being unable to verify benefits eligibility. Furthermore, some practices were forced to utilize personal funds to cover expenses or borrow to keep the business afloat.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
